Hospital News and Research

RSS

Critical Diagnostics' high sensitivity Presage ST2 Assay receives CE Mark approval

Critical Diagnostics announced today that it has received CE (Conformité Européenne) Mark for its high sensitivity Presage ST2 Assay and is commencing commercialization in Europe. The product is indicated for use as an aid in risk stratification of patients with heart failure or acute coronary syndrome. This regulatory milestone marks the first time that an assay has become commercially available for the clinical measurement of the biomarker soluble ST2.

7 Jan 2011

BIND Biosciences commences BIND-014 Phase 1 clinical trial in cancer

BIND Biosciences announced today that it has initiated a Phase 1 clinical trial to assess the safety, tolerability and pharmacokinetic profile of BIND-014 in cancer patients. BIND-014, the first product candidate to enter clinical evaluation from BIND's broad proprietary Medicinal Nanoengineering platform, is a targeted polymeric nanoparticle containing the cytotoxic agent, docetaxel.

7 Jan 2011

World's largest medical robotic conference

The International Robotic Urology Symposium 2011 is hosted by the Henry Ford Vattikuti Urology Institute and the Vattikuti Foundation.

7 Jan 2011

Elevated rates of 'Sarcoid Like' Granulomatous Pulmonary Disease found in WTC responders

Mount Sinai researchers coordinating the largest clinical study to date of "Sarcoid Like" Granulomatous Pulmonary Disease in World Trade Center (WTC) responders have found that the rate of the condition was increased in this group as compared to the records of pre-9/11 FDNY personnel. The study is published online in the American Journal of Industrial Medicine.

7 Jan 2011

IDSA releases MRSA treatment guidelines

Physicians now have help in their battle against methicillin resistant Staphylococcus aureus (MRSA), a potentially deadly infection that initially was limited to hospitals and health care facilities but has become a growing problem in healthy children and adults. The Infectious Diseases Society of America (IDSA) has released its first guidelines for the treatment of increasingly common MRSA infections.

7 Jan 2011

Massachusetts General borrows $420 million for improvements; Detroit hospital penalty reveals new trend

Partners HealthCare System Inc., which runs Boston's Massachusetts General Hospital, is borrowing $420 million for improvements including electronic medical records and to refinance debt, with average tax-exempt yields at close to a 16-month high.

7 Jan 2011

Cell Medica enters EBV-associated cancer research collaboration with CAGT and Baylor College of Medicine

Cell Medica, a leading cellular therapeutics company which develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, is pleased to announce an exclusive license agreement and research collaboration with the Center for Cell and Gene Therapy (CAGT), Baylor College of Medicine (Houston, Texas), for the commercialization of an innovative cell-based treatment for cancers associated with the oncogenic Epstein Barr virus (EBV).

7 Jan 2011

Study examines link between media consumption, eating disorders among adolescent girls in Fiji

For parents wanting to reduce the negative influence of TV on their children, the first step is normally to switch off the television set. But a new study suggests that might not be enough. It turns out indirect media exposure, i.e., having friends who watch a lot of TV, might be even more damaging to a teenager's body image.

7 Jan 2011

Roundup: In Oregon, New Gov. Kitzhaber vows to change state's health care delivery system; In Ariz., 2nd person denied transplant coverage dies

Oregon Governor-elect John Kitzhaber, a Democrat who will be inaugurated in Salem on Monday (January 10), is no stranger to the state's top political office: He was a two-term governor between 1995 and 2003. ... An emergency-room physician by background, Kitzhaber, 62, also is no stranger to the nation's health care system, which he sees as costly, ineffective and unsustainable.

7 Jan 2011

HRG protein inhibits tumor growth and metastasis: Study

Most cancer tissues are invaded by inflammatory cells that either stimulate or inhibit the growth of the tumor, depending on what immune cells are involved. Now a Swedish-Belgian research team has shown that a protein that naturally occurs in the body, HRG, inhibits tumor growth and metastasis into secondary organs by activating specific immune cells.

7 Jan 2011

Positive results from LifeCycle Pharma's LCP-Tacro comparative trial in de novo liver transplant patients

LifeCycle Pharma A/S has announced positive top-line results from a Phase 2 clinical trial involving 58 patients comparing LCP-Tacro™ tablets administered once-daily versus Prograf® (tacrolimus) capsules (Astellas Pharma) administered twice-daily in de novo liver transplant patients for one year.

7 Jan 2011

Saints Medical Center enters multi-faceted agreement with ZOLL

Saints Medical Center, a leading non-profit healthcare facility in the Greater Lowell area, is pleased to announce it has entered into a multi-faceted agreement with ZOLL Medical Corporation (Nasdaq: ZOLL) of Chelmsford, Mass., a leader in comprehensive hospital and EMS resuscitation solutions. This agreement includes the Saints-based EMS service working with ZOLL to collaborate on and test new product concepts and technology concepts.

7 Jan 2011

Better monitoring, new techniques reduce anesthesia-related maternal deaths

The number of women who die from complications of anesthesia during childbirth has plummeted 59 percent over the last two decades thanks to improved monitoring and better medical techniques, according to a recent study.

7 Jan 2011

Administration reverses federal rule on End-of-life planning

News outlets are reporting that some observers view the step an "embarrassing episode" for the administration and note that some of the rule's supporters consider it a "flip flop." All in all, the rule change and the reaction to it appear to highlight the continued politics that surround the issue.

7 Jan 2011

U.S. health expenditures increased 4% in 2009

This increase represents the smallest one in at least a half a century. At the same time, though, medical costs ate up a record share of the overall economy. Experts pointed to the recession as a key explanation.

7 Jan 2011

Virdante Pharmaceuticals receives US key patent for Sialic Switch technology

Virdante Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office has granted a key patent that supports the Company's "Sialic Switch" technology for improving the anti-inflammatory activity of antibody-based drugs to treat autoimmune and inflammatory disorders.

7 Jan 2011

New research: NFKBIA gene loss induces glioblastoma development

New research shows that loss of a gene called NFKBIA promotes the growth of glioblastoma multiforme, the most common and deadly form of brain cancer, and suggests that therapies that stabilize this gene may improve survival for certain glioblastoma patients.

7 Jan 2011

Acceleron recieves $1.5 million MDA grant for ACE-031 clinical study in Duchenne Muscular Dystrophy

Acceleron Pharma, a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced it has been awarded a $1.5 million grant from the Muscular Dystrophy Association to support clinical studies of ACE-031 in Duchenne Muscular Dystrophy, a disabling neuromuscular disease in which patients experience a progressive loss of muscle mass and strength.

6 Jan 2011

MacroGenics commences MGAH22 Phase I trail for patients with HER2-positive cancer

MacroGenics, a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced that it had administered drug to the first cohort of patients in a Phase I clinical trial of MGAH22.

6 Jan 2011

22.5% implanted defibrillators are unnecessary: Study

According to a new study nearly 20% of American patients who receive an implantable cardioverter-defibrillator (ICD) may not need it. These ICDs when unnecessary could put the patients at higher risk of death and serious complications than patients who meet the criteria for the life-saving device say authors of the study published in the Jan. 5 issue of the Journal of the American Medical Association.

6 Jan 2011

Hospital News and Research

Critical Diagnostics' high sensitivity Presage ST2 Assay receives CE Mark approval

BIND Biosciences commences BIND-014 Phase 1 clinical trial in cancer

World's largest medical robotic conference

Elevated rates of 'Sarcoid Like' Granulomatous Pulmonary Disease found in WTC responders

IDSA releases MRSA treatment guidelines

Massachusetts General borrows $420 million for improvements; Detroit hospital penalty reveals new trend

Cell Medica enters EBV-associated cancer research collaboration with CAGT and Baylor College of Medicine

Study examines link between media consumption, eating disorders among adolescent girls in Fiji

Roundup: In Oregon, New Gov. Kitzhaber vows to change state's health care delivery system; In Ariz., 2nd person denied transplant coverage dies

HRG protein inhibits tumor growth and metastasis: Study

Positive results from LifeCycle Pharma's LCP-Tacro comparative trial in de novo liver transplant patients

Saints Medical Center enters multi-faceted agreement with ZOLL

Better monitoring, new techniques reduce anesthesia-related maternal deaths

Administration reverses federal rule on End-of-life planning

U.S. health expenditures increased 4% in 2009

Virdante Pharmaceuticals receives US key patent for Sialic Switch technology

New research: NFKBIA gene loss induces glioblastoma development

Acceleron recieves $1.5 million MDA grant for ACE-031 clinical study in Duchenne Muscular Dystrophy

MacroGenics commences MGAH22 Phase I trail for patients with HER2-positive cancer

22.5% implanted defibrillators are unnecessary: Study

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News